|
DZ2376A1
(fr)
*
|
1996-12-19 |
2002-12-28 |
Smithkline Beecham Plc |
Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
|
|
TR200000073T2
(tr)
*
|
1997-07-11 |
2000-06-21 |
Smithkline Beecham P.L.C. |
5-HT6 Reseptör antagonistleri olan sülfonamid türevleri ve bunların hazırlanma prosesi
|
|
ES2317688T3
(es)
|
1998-01-29 |
2009-04-16 |
Amgen Inc. |
Moduladores ppar-gamma.
|
|
GB9803411D0
(en)
*
|
1998-02-18 |
1998-04-15 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6194410B1
(en)
|
1998-03-11 |
2001-02-27 |
Hoffman-La Roche Inc. |
Pyrazolopyrimidine and pyrazolines and process for preparation thereof
|
|
GB9810671D0
(en)
*
|
1998-05-18 |
1998-07-15 |
Pfizer Ltd |
Anti-pruritic agents
|
|
GB9818916D0
(en)
|
1998-08-28 |
1998-10-21 |
Smithkline Beecham Plc |
Use
|
|
GB9818914D0
(en)
*
|
1998-08-28 |
1998-10-21 |
Smithkline Beecham Plc |
Use
|
|
GB9820113D0
(en)
|
1998-09-15 |
1998-11-11 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US7041691B1
(en)
|
1999-06-30 |
2006-05-09 |
Amgen Inc. |
Compounds for the modulation of PPARγ activity
|
|
GB9926302D0
(en)
*
|
1999-11-05 |
2000-01-12 |
Smithkline Beecham Plc |
Novel compounds
|
|
AU2441801A
(en)
*
|
1999-12-21 |
2001-07-03 |
Smithkline Beecham Corporation |
Urotensin-ii receptor antagonists
|
|
SE9904723D0
(sv)
*
|
1999-12-22 |
1999-12-22 |
Carlsson A Research Ab |
New modulators of dopamine neurotransmission II
|
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
US20030171399A1
(en)
|
2000-06-28 |
2003-09-11 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
|
SE0002754D0
(sv)
*
|
2000-07-21 |
2000-07-21 |
Pharmacia & Upjohn Ab |
New pharmaceutical combination formulation and method of treatment with the combination
|
|
US6399617B1
(en)
|
2000-07-21 |
2002-06-04 |
Biovitrum Ab |
Use
|
|
US6818639B2
(en)
|
2000-07-21 |
2004-11-16 |
Biovitrum Ab |
Pharmaceutical combination formulation and method of treatment with the combination
|
|
SE0002739D0
(sv)
*
|
2000-07-21 |
2000-07-21 |
Pharmacia & Upjohn Ab |
New use
|
|
AU2001288053A1
(en)
*
|
2000-09-18 |
2002-03-26 |
Toa Eiyo Ltd. |
N-substituted benzothiophenesulfonamide derivatives
|
|
US7071220B2
(en)
|
2000-09-18 |
2006-07-04 |
Toa Eiyo Ltd. |
N-substituted benzothiophenesulfonamide derivatives
|
|
US7034029B2
(en)
|
2000-11-02 |
2006-04-25 |
Wyeth |
1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
|
|
JP2004517826A
(ja)
|
2000-11-21 |
2004-06-17 |
スミスクライン ビーチャム パブリック リミテッド カンパニー |
Ｃｎｓ障害の治療において有用なイソキノリン誘導体
|
|
WO2002051397A1
(en)
|
2000-12-22 |
2002-07-04 |
Ishihara Sangyo Kaisha, Ltd. |
Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
|
|
US20030095958A1
(en)
*
|
2001-04-27 |
2003-05-22 |
Bhisetti Govinda R. |
Inhibitors of bace
|
|
WO2002089793A1
(en)
*
|
2001-05-07 |
2002-11-14 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
US6743796B2
(en)
*
|
2001-05-07 |
2004-06-01 |
Wyeth |
Piperazinyl-isatins
|
|
JP2005508852A
(ja)
*
|
2001-05-07 |
2005-04-07 |
スミスクライン・ビーチャム・コーポレイション |
スルホンアミド
|
|
JP2004529168A
(ja)
*
|
2001-05-07 |
2004-09-24 |
スミスクライン・ビーチャム・コーポレイション |
スルホンアミド
|
|
JP2004535390A
(ja)
*
|
2001-05-07 |
2004-11-25 |
スミスクライン・ビーチャム・コーポレイション |
スルホンアミド
|
|
AR033879A1
(es)
*
|
2001-05-07 |
2004-01-07 |
Smithkline Beecham Corp |
Compuesto sulfonamida, composicion farmaceutica que lo comprende, su uso para preparar dicha composicion y procedimiento para la obtencion de dicho compuesto
|
|
GB0111186D0
(en)
*
|
2001-05-08 |
2001-06-27 |
Smithkline Beecham Plc |
Novel compounds
|
|
RS88803A
(sr)
*
|
2001-05-11 |
2007-02-05 |
Biovitrum Ab., |
Nova jedinjenja arilsulfonamida za lečenje gojaznosti, dijabetesa tipa ii i poremećaja cns
|
|
US7718650B2
(en)
|
2001-05-11 |
2010-05-18 |
Biovitrum Ab |
Aryl sulfonamide compounds for treating obesity
|
|
JP4597480B2
(ja)
|
2001-05-11 |
2010-12-15 |
プロキシマゲン・リミテッド |
肥満、ｉｉ型糖尿病およびｃｎｓ疾患の処置のための新規アリールスルホンアミド化合物
|
|
SK16052003A3
(en)
|
2001-06-07 |
2004-10-05 |
Hoffmann La Roche |
New indole derivatives with 5-HT6 receptor affinity
|
|
CA2445653A1
(en)
|
2001-06-11 |
2002-12-19 |
Biovitrum Ab |
Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
|
|
MXPA03011638A
(es)
|
2001-06-15 |
2004-04-02 |
Hoffmann La Roche |
Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
|
|
US6727264B1
(en)
|
2001-07-05 |
2004-04-27 |
Synaptic Pharmaceutical Corporation |
Substituted anilinic piperidines as MCH selective antagonists
|
|
JP2005527463A
(ja)
*
|
2001-08-07 |
2005-09-15 |
スミスクライン ビーチャム パブリック リミテッド カンパニー |
Ｃｎｓ疾患を治療するための５−ｈｔ６受容体アフィニティーを有する３−アリールスルホニル−７−ピペラジニル−インドール、−ベンゾフランおよび−ベンゾチオフェン
|
|
JP4187650B2
(ja)
*
|
2001-08-10 |
2008-11-26 |
エフ．ホフマン−ラ ロシュ アーゲー |
５−ｈｔ６レセプター親和性を有するアリールスルホニル誘導体
|
|
TWI325317B
(en)
*
|
2001-09-05 |
2010-06-01 |
Eisai R&D Man Co Ltd |
Appetite-stimulating agents and remedies for anorexia
|
|
SE0103644D0
(sv)
*
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic isoquinoline compounds
|
|
ATE429916T1
(de)
*
|
2001-11-09 |
2009-05-15 |
Biovitrum Ab Publ |
Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
|
|
US7074788B2
(en)
|
2001-11-22 |
2006-07-11 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
RS44304A
(sr)
|
2001-11-22 |
2007-06-04 |
Biovitrum Ab., |
Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1
|
|
ES2290346T3
(es)
*
|
2001-11-30 |
2008-02-16 |
F. Hoffmann-La Roche Ag |
Derivados de piperazina para uso como antagonistas del receptor ccr-3 en tratamiento de asma.
|
|
EP1471912A1
(en)
*
|
2002-02-05 |
2004-11-03 |
Glaxo Group Limited |
Method of promoting neuronal growth
|
|
CN1628109A
(zh)
*
|
2002-02-05 |
2005-06-15 |
诺沃挪第克公司 |
新颖的芳基－与杂芳基－哌嗪
|
|
DE60304695T2
(de)
*
|
2002-02-13 |
2006-09-21 |
Glaxo Group Ltd., Greenford |
7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo[d]azepin-derivate mit 5-hat-6-rezeptor affinität zur behandlung von erkrankungen des zentralnervensystems
|
|
CN1630642A
(zh)
*
|
2002-02-13 |
2005-06-22 |
葛兰素集团有限公司 |
苯磺酰胺衍生物
|
|
EP1495004A2
(en)
*
|
2002-02-13 |
2005-01-12 |
Glaxo Group Limited |
Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor ligands
|
|
ATE398108T1
(de)
*
|
2002-03-27 |
2008-07-15 |
Glaxo Group Ltd |
Chinolinderivate und deren verwendung als 5-ht6 liganden
|
|
US20040142948A1
(en)
*
|
2002-05-07 |
2004-07-22 |
Dashyant Dhanak |
Sulfonamides
|
|
NZ536230A
(en)
*
|
2002-05-13 |
2007-05-31 |
Hoffmann La Roche |
Benzoxazine derivatives as 5-hydroxytryptamine-6 (5-HT6) modulatory neurotransmitter in the brain
|
|
EP1897876A3
(en)
|
2002-06-20 |
2009-03-18 |
Biovitrum AB (publ) |
Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
|
US7943639B2
(en)
*
|
2002-06-20 |
2011-05-17 |
Proximagen Limited |
Compounds
|
|
NZ552283A
(en)
*
|
2002-06-20 |
2008-07-31 |
Biovitrum Ab Publ |
New compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
|
ATE344030T1
(de)
|
2002-10-18 |
2006-11-15 |
Hoffmann La Roche |
4-piperazinylbenzolsulfonyl-indole mit 5-ht6 rezeptor-affinität
|
|
WO2004043368A2
(en)
*
|
2002-11-06 |
2004-05-27 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
AU2003291262A1
(en)
*
|
2002-11-06 |
2004-06-03 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
HRP20050696B1
(en)
|
2003-01-14 |
2008-10-31 |
Arena Pharmaceuticals Inc. |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
|
US7153858B2
(en)
|
2003-01-31 |
2006-12-26 |
Epix Delaware, Inc. |
Arylpiperazinyl compounds
|
|
WO2004072087A2
(de)
*
|
2003-02-13 |
2004-08-26 |
Lanxess Deutschland Gmbh |
Metallkomplexe als lichtabsorbierende verbindungen in der informationsschicht von optischen datenträgern
|
|
AU2004212985B2
(en)
*
|
2003-02-20 |
2010-10-14 |
Encysive Pharmaceuticals Inc. |
Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
|
|
TWI289141B
(en)
|
2003-03-11 |
2007-11-01 |
Hoffmann La Roche F. Ag. |
Quinolinone derivatives and uses thereof
|
|
WO2004087654A2
(en)
*
|
2003-03-31 |
2004-10-14 |
Janssen Pharmaceutica N.V. |
Phospholipase c inhibitors for use in treating inflammatory disorders
|
|
US6946466B2
(en)
*
|
2003-04-10 |
2005-09-20 |
Schering Ag |
Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
|
|
US20040204422A1
(en)
*
|
2003-04-14 |
2004-10-14 |
Abbott Gmbh & Co. Kg. |
N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
|
|
HRP20060100T3
(en)
|
2003-07-22 |
2007-03-31 |
Arena Pharmaceuticals Inc |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
GB0320320D0
(en)
*
|
2003-08-29 |
2003-10-01 |
Glaxo Group Ltd |
Novel compounds
|
|
US7223761B2
(en)
|
2003-10-03 |
2007-05-29 |
Amgen Inc. |
Salts and polymorphs of a potent antidiabetic compound
|
|
EP1694663A1
(en)
*
|
2003-12-19 |
2006-08-30 |
Biovitrum Aktiebolag |
Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder
|
|
SE0303480D0
(sv)
*
|
2003-12-19 |
2003-12-19 |
Biovitrum Ab |
Benzofuranes
|
|
AU2005266448A1
(en)
|
2004-07-28 |
2006-02-02 |
Glaxo Group Limited |
Piperazine derivatives useful for the treatment of gastrointestinal disorders
|
|
DE602005026543D1
(de)
*
|
2004-09-30 |
2011-04-07 |
Hoffmann La Roche |
Zusammensetzungen und verfahren zur behandlung kognitiver störungen
|
|
EP2311803A1
(en)
|
2004-10-14 |
2011-04-20 |
Abbott GmbH & Co. KG |
Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
|
|
MX2007004358A
(es)
|
2004-10-14 |
2007-07-17 |
Abbott Gmbh & Co Kg |
Compuestos de azabicicloheptilo adecuados para tratar trastornos que responden a la modulacion del receptor de dopamina d3.
|
|
WO2006062481A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Biovitrum Ab |
New benzofuran derivatives and their use in the treatment of obesity, type ii diabetes and cns disorders .
|
|
EP1676841A1
(en)
*
|
2004-12-30 |
2006-07-05 |
Esteve Laboratorios Dr. Esteve S.A. |
Substitited indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their prepartion and use in medicaments
|
|
WO2006075808A1
(en)
*
|
2005-01-12 |
2006-07-20 |
Inje University |
Pharmaceutical composition comprising a p25/cdk5 inhibitor for preventing or treating a neurodegenerative disease
|
|
BRPI0613564A2
(pt)
|
2005-07-04 |
2011-01-18 |
Novo Nordisk As |
compostos, seus usos na preparação de composições farmacêuticas e composições farmacêuticas compreendendo os mesmos
|
|
BRPI0520579B8
(pt)
|
2005-08-12 |
2021-05-25 |
Suven Life Sciences Ltd |
composto, processo para a preparação de um composto e composição farmacêutica
|
|
KR101250820B1
(ko)
|
2005-08-16 |
2013-04-04 |
수벤 라이프 사이언시스 리미티드 |
개선된 로사르탄 제조 방법
|
|
EP1976495A2
(en)
*
|
2006-01-06 |
2008-10-08 |
Aarhus Universitet |
Compounds acting on the serotonin transporter
|
|
WO2007113202A1
(en)
|
2006-03-31 |
2007-10-11 |
Glaxo Group Limited |
Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists
|
|
EP2029528A1
(en)
*
|
2006-04-19 |
2009-03-04 |
Abbott GmbH & Co. KG |
Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
|
|
EP2074110A1
(en)
|
2006-04-19 |
2009-07-01 |
Abbott GmbH & Co. KG |
Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
|
|
US8318927B2
(en)
|
2006-05-23 |
2012-11-27 |
High Point Pharmaceuticals, Llc |
6-(4-cyclopropylpiperazin-1-yl)-2′-methyl-[3, 4′]-bipyridine and its uses as a medicament
|
|
AU2007267197B2
(en)
|
2006-05-29 |
2011-12-01 |
High Point Pharmaceuticals, Llc |
3- (1, 3-Benzodioxol-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine H3 receptor antagonist
|
|
WO2008052190A2
(en)
*
|
2006-10-26 |
2008-05-02 |
Flynn Gary A |
Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
|
|
ES2357584T3
(es)
|
2007-01-08 |
2011-04-27 |
Suven Life Sciences Limited |
Compuestos de 5-(heterociclil) alquil-n-(arilsulfonil)indol y su uso como ligandos de 5-th6.
|
|
CN101578265B
(zh)
*
|
2007-01-10 |
2013-05-08 |
霍夫曼-拉罗奇有限公司 |
用作糜蛋白酶抑制剂的磺酰胺衍生物
|
|
WO2008116833A1
(en)
|
2007-03-23 |
2008-10-02 |
Abbott Gmbh & Co. Kg |
Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
|
|
ES2366496T3
(es)
|
2007-05-03 |
2011-10-20 |
Suven Life Sciences Limited |
Compuestos de aminoalcoxi arilsulfonamida y su uso como ligandos 5-ht6.
|
|
EP2014656A3
(en)
|
2007-06-11 |
2011-08-24 |
High Point Pharmaceuticals, LLC |
New heteocyclic h3 antagonists
|
|
ATE499099T1
(de)
*
|
2007-07-19 |
2011-03-15 |
Esteve Labor Dr |
Substituierte tetrahydro- chinolinsulfonamidverbindungen, ihre herstellung und ihre verwendung als medikamente
|
|
CA2703157C
(en)
|
2007-10-26 |
2013-02-05 |
Suven Life Sciences Limited |
Amino arylsulfonamide compounds and their use as 5-ht6 ligands
|
|
PA8802201A1
(es)
*
|
2007-11-02 |
2009-06-23 |
Abbott Gmbh & Co Kg |
Compuestos de bencensulfonalida apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6
|
|
US9084742B2
(en)
|
2007-12-12 |
2015-07-21 |
Axovant Sciences Ltd. |
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline
|
|
WO2009123714A2
(en)
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
US20110034565A1
(en)
|
2008-04-18 |
2011-02-10 |
University College Dublin, National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
|
EA201001847A1
(ru)
*
|
2008-06-11 |
2011-08-30 |
Айрм Ллк |
Соединения и композиции, применяемые для лечения малярии
|
|
US8318725B2
(en)
|
2008-09-17 |
2012-11-27 |
Suven Life Sciences Limited |
Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
|
|
BRPI0913736A2
(pt)
|
2008-09-17 |
2023-04-11 |
Suven Life Sciences Ltd |
Composto, processo para a preparação do composto, composição farmacêutica e método para o tratamento de uma desordem do sistema nervoso central
|
|
WO2010062321A1
(en)
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
|
UA100192C2
(en)
|
2008-11-11 |
2012-11-26 |
УАЙТ ЭлЭлСи |
1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
|
|
KR101073703B1
(ko)
|
2009-04-07 |
2011-10-14 |
한국화학연구원 |
피페라진 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 중추신경계 질환의 예방 또는 치료용 약학적 조성물
|
|
MX2011011519A
(es)
|
2009-04-30 |
2012-01-30 |
Abbott Gmbh & Co Kg |
Compuestos de bencensulfonanilida adecuados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6.
|
|
CN102459197B
(zh)
|
2009-04-30 |
2015-08-19 |
Abbvie公司 |
适用于治疗响应血清素5-ht6受体的调节的病症的n-苯基-(哌嗪基或高哌嗪基)-苯磺酰胺或苯磺酰基-苯基-(哌嗪或高哌嗪)化合物
|
|
US8343959B2
(en)
|
2009-04-30 |
2013-01-01 |
Abbott Gmbh & Co. Kg |
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
US8362010B2
(en)
|
2009-04-30 |
2013-01-29 |
Abbott Gmbh & Co. Kg |
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
CA2786072C
(en)
|
2010-01-05 |
2014-10-28 |
Suven Life Sciences Limited |
Sulfone compounds as 5-ht6 receptor ligands
|
|
MX2013003184A
(es)
|
2010-09-22 |
2013-06-07 |
Arena Pharm Inc |
Moduladores del receptor gpr119 y el tratamiento de transtornos relacionados con el mismo.
|
|
WO2012059431A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
|
|
WO2012059432A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
|
|
ES2413911B1
(es)
*
|
2011-12-15 |
2014-05-14 |
Universidad De Zaragoza |
Agente inhibidor de la agregación del peptido beta amiloide.
|
|
KR20140135835A
(ko)
|
2012-03-20 |
2014-11-26 |
아다메드 에스피. 제트 오.오. |
Cns 질환의 치료를 위한 벤질아민의 설폰아미드 유도체
|
|
DK2970205T3
(da)
|
2013-03-14 |
2019-07-29 |
Tolero Pharmaceuticals Inc |
JAK2- og ALK2-inhibitorer og fremgangsmåder til anvendelse deraf
|
|
JP6267334B2
(ja)
|
2013-07-25 |
2018-01-24 |
ユニベルシテット ヤギェウォＵｎｉｗｅｒｓｙｔｅｔ Ｊａｇｉｅｌｌｏｎｓｋｉ |
５−ｈｔ６拮抗薬としてのピロロキノリン誘導体、それらの製造方法および使用
|
|
US9840482B2
(en)
|
2014-04-19 |
2017-12-12 |
Sunshine Lake Pharma Co., Ltd. |
Sulfonamide derivatives and pharmaceutical applications thereof
|
|
CN105367473B
(zh)
*
|
2014-08-12 |
2020-02-11 |
广东东阳光药业有限公司 |
吲哚啉类衍生物及其在药物上的应用
|
|
CN105367472B
(zh)
*
|
2014-08-12 |
2020-04-21 |
广东东阳光药业有限公司 |
吲哚啉类衍生物及其在药物上的应用
|
|
US11007175B2
(en)
|
2015-01-06 |
2021-05-18 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
|
JP2018516992A
(ja)
|
2015-06-12 |
2018-06-28 |
アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ |
レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
|
|
BR112017027656B1
(pt)
|
2015-06-22 |
2023-12-05 |
Arena Pharmaceuticals, Inc. |
Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
|
|
WO2017011767A2
(en)
|
2015-07-15 |
2017-01-19 |
Axovant Sciences Ltd. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease
|
|
CN108926565A
(zh)
*
|
2017-05-26 |
2018-12-04 |
中国科学院上海生命科学研究院 |
五羟色胺受体亚型6小分子激活剂及拮抗剂在防治阿尔茨海默症中的应用
|
|
WO2019180176A1
(en)
|
2018-03-21 |
2019-09-26 |
Spherium Biomed, S.L. |
Composition for the treatment of schizophrenia and/or psychosis
|
|
BR112020024762A2
(pt)
|
2018-06-06 |
2021-03-23 |
Arena Pharmaceuticals, Inc. |
métodos de tratamento de condições relacionadas ao receptor s1p1
|
|
CN112512597A
(zh)
|
2018-07-26 |
2021-03-16 |
大日本住友制药肿瘤公司 |
用于治疗与acvr1表达异常相关的疾病的方法以及用于此的acvr1抑制剂
|